QA

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

Zenotech is a subsidiary company of Sun Pharma is the India's largest and most valuable pharmaceutical enterprise by size and market capitalization. The company provides high quality medicines trusted by customers and patients in over 150 countries and has multiple manufacturing facilities and R & D centres. Our leadership is approachable, recognizes people's passions for growth ,gives them a voice and empowers them to make a positive change. To keep pace with our growth plans, we require high potential talent for our Biologics& formulation manufacturing plant at Hyderabad.

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation. Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

Stelis is committed to making biological treatments accessible to patients globally. Our products are targeted against large treatment markets that are currently underserved.  Our hybrid operating model combines differentiated bio-similar, novel biologics and authorized manufacture and marketing of in-licensed biologics. With R&D and cGMP manufacturing out of Bangalore, India we aim to bring world-class treatments at affordable costs to patients in Emerging and Developed countries.

Sun Pharmaceutical Industries Limited is the fourth largest specialty generic pharmaceutical company in the world. We provide high-quality, affordable medicine trusted by healthcare professionals and patients in over 150 countries. It is also India’s la most trusted and most valuable pharmaceutical company by market capitalization.

Accuprec Research Labs Pvt Ltd. is FDCA approved, NABL accredited and ISO 9001:2015 certified CRO. Head Quarter of the CRO is located at Ahmedabad and branch offices at Canada and USA. Accuprec provides all type of Pharmaceutical testing solutions to its domestic and MNC clients. Accuprec requires below mentioned staff. Excellent Salary and other benefits will be provided to deserving candidates.

Intas Pharmaceuticals headquartered at Ahmedabad (India), is now a force to reckon with, in the global pharma horizon. With expertise in a range of formulations, from tablets to injectables to newer drug delivery systems, Intas is currently ranked 18th among the Indian Pharma majors.

Established in 2016, ANNORA Pharma is committed to provide medicines with highest quality, safety and efficacy that meets the needs of the customers with applicable statutory and regulatory requirements.  Spread over in thirty-five acres land, our manufacturing facility close to the city of Hyderabad, India specializes in manufacturing of Tablets, Capsules, Pellets, Liquid Orals, Suppositories and Dry Powder Syrups catering to a diverse therapeutic range.  Our state-of-the-art manufacturing facility is designed to meet the standards conforming to Schedule M of Indian Drugs & Cosmetics Act, USFDA and European Regulatory Agency’s Guidelines.

Novo Nordisk (NN) Quality India department was established in May 2015, with a purpose of delivering services related to quality processes such training coordination and document control, NovoGloW (Quality & Compliance Management platform), Records Management to various internal clients within Novo Nordisk. The main purpose of our existence is to provide superior service to our stakeholders consistently and add value to the processes in terms of standardisation and efficiency.